Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-26

FDA Approved: SUMATRIPTAN — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Sumatriptan (generic) filed by Lannett Company, Inc., expanding the availability of this migraine medication under t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (generic) (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)